Retrospective analysis of severe COVID-19 pneumonia patients treated with lopinavir/ritonavir: A comparison with survivor and non-survivor patients

by Omer Ayten, Bengu Saylan
Published 2020-12-01

Do New Drugs Meet the Expectations in the Treatment of Idiopathic Pulmonary Fibrosis?

by Oğuzhan Okutan, Ömer Ayten
Published 2016-04-01

Comparison of non-severe COVID-19 pneumonia patients treated with lopinavir/ritonavir and favipiravir

by Bengü Şaylan, Omer Ayten
Published 2020-11-01

Potential treatment of COVID-19

by Omer Ayten, Cengiz Özdemir, Ülkü Aka Aktürk, Nazan Şen
Published 2020-01-01

Proadrenomedullin determining clinical severity and analyzing prognostic value for pneumonia

by Sedat Demirsoy, Oğuzhan Okutan, Zafer Kartaloglu, Dilaver Taş, Ömer Ayten, Kadir Canoglu
Published 2019-01-01